Bavarian Nordic CEO receives "extraordinary" retention bonus
The Covid-19 pandemic has created high demand for executives with vaccine experience, and Bavarian Nordic has chosen to protect its President and CEO Paul Chaplin from poaching attempts by putting some cash aside to keep him in the fold.
BY RITZAU, TRANSLATED BY DANIEL PEDERSEN
Bavarian Nordic, which is developing a Covid-19 vaccine, has given its CEO Paul Chaplin a grant of millions of kroner to keep him in the company.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
